Educational Symposium held during the ISPOR 15th Annual International Meeting
THE 7 ESSENTIALS OF SUCCESSFUL HEALTH ECONOMIC COMMUNICATION
Monday, May 17, 2010
7:00AM-8:00AM
Sponsored by Medaxial
Symposia are free and open to all ISPOR delegates, no pre-registration required.
In an era of extreme pressure on healthcare spending, the role of health economists has never been more important. Yet the contribution health economists can make to rational resource use is undermined by incomprehension, skepticism and even hostility from many outsiders – including colleagues, commentators and healthcare decision-makers. But what exactly is it that makes health economics so hard to communicate? And what can done to address the problem? The 7 essential principles of successful health economic communication will be presented.
Educational Symposium held during the ISPOR 15th Annual International Meeting
WILL COMPARATIVE EFFECTIVENESS RESEARCH SURVIVE HEALTH REFORM?
Monday, May 17, 2010
12:30PM-1:30PM
Sponsored by IMS Health
Symposia are free and open to all ISPOR delegates, no pre-registration required.
The Comparative Effectiveness Research (CER) movement was re-triggered by $1.1B in funding from the U.S. government stimulus package. Many have joined the CER bandwagon calling for more CER research to aid payer, provider and patient decision making. However, as of this writing, the future of government funding for CER is uncertain. While both the Senate and House Health Reform bills contained mechanisms for on-going government funding of CER, the future of public funding for CER is in doubt. Obama's budget calls for HRQ's CER budget to grow tenfold in 2011. Whether this will survive intact is an open question. The question now is will the CER movement lose momentum and go the way of the ill-fated Office of Technology Assessment, or is there sufficient momentum from academics, research groups, payers and even pharmaceutical and other manufacturers to keep the movement alive. Will the CER movement lose momentum and go the way of the ill-fated Office of Technology Assessment? What will CER in the post-health reform era look like? Speakers representing payers, research, and the industry will discuss the future of CER research in the United States and highlight implications for the global market place.
